Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$5.19 - $8.07 $5,812 - $9,038
1,120 New
1,120 $7,000
Q4 2022

Jan 23, 2023

SELL
$5.8 - $8.98 $887 - $1,373
-153 Reduced 2.15%
6,967 $0
Q3 2022

Oct 26, 2022

BUY
$7.55 - $11.25 $22,159 - $33,018
2,935 Added 70.13%
7,120 $59,000
Q2 2022

Jul 25, 2022

SELL
$6.8 - $14.23 $96,770 - $202,507
-14,231 Reduced 77.28%
4,185 $31,000
Q1 2022

May 02, 2022

BUY
$13.42 - $23.38 $37,710 - $65,697
2,810 Added 18.01%
18,416 $0
Q4 2021

Jan 28, 2022

BUY
$12.78 - $23.74 $199,444 - $370,486
15,606 New
15,606 $370,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $283M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.